1. Uterine Sarcoma 2. Challenging Rare->Limited data Rapidly growing (doubling time is 4 weeks) tend to be increasing(Nordal & Thoresen 1997) 3. Epidemiology Rare2%…
1. 16 Journal of Indian Association of Pediatric Surgeons / Jan-Mar 2013 / Vol 18 / Issue 1 gonadotrophic hormone) was done in only 8 patients of suspected teratoma. Fourteen…
Slide 1STAGING MCR Staff Show Me Healthy Women March 27, 2008 Supported by a Cooperative Agreement between DHSS and the Centers for Disease Control and Prevention (CDC) and…
Slide 1 Taxanes for Ovarian Cancer: Progress Report Rosemary Tate Information Projects Team December 2000 Slide 2 Background Issues Recent research evidence has shown improved…
Slide 1 Hereditary ovarian/breast cancers (HOC/HBOC) Chair and Department of Surgical Gynecology and Gynecological Oncology of Adults and Adolescents. Head: Prof. zw. dr…
Systemic Therapy for Uterine Cancer Helen J. Mackay Princess Margaret Hospital, University of Toronto Uterine malignancy Endometroid UPSC Clear cell Mucinous Squamous Mixed…
ESGO 1-st Basic Course in Gynecological Oncology Yerevan, State Medical University 30thSeptember - 1st October 2010 The role of the Lymphadenectomy in Endometrial Cancer…
Systemic Therapy for Uterine Cancer Helen J. Mackay Princess Margaret Hospital, University of Toronto Uterine malignancy Endometroid UPSC Clear cell Mucinous Squamous Mixed…
PrintFIGO COMMITTEE ON GYNECOLOGIC ONCOLOGY Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Thefirst rules for classification and stagingof female